Human cytosolic tRNase ZL can downregulate gene expression through miRNA

FEBS Letters

Volumn 583, Issue 19, 2009, Pages 3241-3246

  Elbarbary, Reyad A ^a   Takaku, Hiroaki ^a   Uchiumi, Naoto ^a   Tamiya, Hiroko ^a   Abe, Mayumi ^a   Nishida, Hiroshi ^a   Nashimoto, Masayuki ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

A long form of tRNase Z; MicroRNA; Non coding RNA; RNA induced silencing complex; Small guide RNA; TRUE gene silencing

Indexed keywords

LUCIFERASE; MICRORNA; TRANSFER RNA;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO CULTURE; PRIORITY JOURNAL; RNA CLEAVAGE; RNA SEQUENCE; RNA STRUCTURE;

BASE SEQUENCE; CELL LINE, TUMOR; CYTOSOL; DOWN-REGULATION; ENDORIBONUCLEASES; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NUCLEIC ACID CONFORMATION;

EID: 70349456506     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.09.015     Document Type: Article

References (30)

1. Nashimoto M. Characterization of the spermidine-dependent, sequence-specific endoribonuclease that requires transfer RNA for its activity. Nucleic Acids Res. 20 (1992) 3737-3742
2. Arg is essential for in vitro specific cleavage of partially synthesized mouse 18S rRNA. Nucleic Acids Res. 21 (1993) 4696-4702
3. Nashimoto M. Conversion of mammalian tRNA 3′ processing endoribonuclease to four-base-recognizing RNA cutters. Nucleic Acids Res. 23 (1995) 3642-3647
4. Nashimoto M. Distribution of both lengths and 5′ terminal nucleotides of mammalian pre-tRNA 3′ trailers reflects properties of 3′ processing endoribonuclease. Nucleic Acids Res. 25 (1997) 1148-1155
5. Takaku H., Minagawa A., Takagi M., and Nashimoto M. A candidate prostate cancer susceptibility gene encodes tRNA 3′ processing endoribonuclease. Nucleic Acids Res. 31 (2003) 2272-2278
6. Takaku H., Minagawa A., Takagi M., and Nashimoto M. The N-terminal half-domain of the long form of tRNase Z is required for the RNase 65 activity. Nucleic Acids Res. 32 (2004) 4429-4438
7. S gene expression. FEBS Lett. 582 (2008) 2532-2536
8. Nashimoto M. Specific cleavage of target RNAs from HIV-1 with 5′ half tRNA by mammalian tRNA 3′ processing endoribonuclease. RNA 2 (1996) 523-534
9. Nashimoto M. Anomalous RNA substrates for mammalian tRNA 3′ processing endoribonuclease. FEBS Lett. 472 (2000) 179-186
10. Nashimoto M., Geary S., Tamura M., and Kaspar R. RNA heptamers that direct RNA cleavage by mammalian tRNA 3′ processing endoribonuclease. Nucleic Acids Res. 26 (1998) 2565-2572
11. Nashimoto M., Tamura M., and Kaspar R.L. Minimum requirements for substrates of mammalian tRNA 3′ processing endoribonuclease. Biochemistry 38 (1999) 12089-12096
12. Takaku H., Minagawa A., Takagi M., and Nashimoto M. A novel 4-base-recognizing RNA cutter that can remove the single 3′ terminal nucleotides from RNA molecules. Nucleic Acids Res. 32 (2004) e91
13. Shibata H.S., Takaku H., Takagi M., and Nashimoto M. The T loop structure is dispensable for substrate recognition by tRNase ZL. J. Biol. Chem. 280 (2005) 22326-22334
14. Tamura M., Nashimoto C., Miyake N., Daikuhara Y., Ochi K., and Nashimoto M. Intracellular mRNA cleavage by 3′ tRNase under the direction of 2′-O-methyl RNA heptamers. Nucleic Acids Res. 31 (2003) 4354-4360
15. Habu Y., Miyano-Kurosaki N., Kitano M., Endo Y., Yukita M., Ohira S., Takaku H., Nashimoto M., and Takaku H. Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL. Nucleic Acids Res. 33 (2005) 235-243
16. L under the direction of small guide RNA. Gene Therapy 14 (2007) 78-85
17. Elbarbary R.A., Takaku H., Tamura M., and Nashimoto M. Inhibition of vascular endothelial growth factor expression by TRUE gene silencing. Biochem. Biophys. Res. Commun. 379 (2009) 924-927
18. L through 5′-half-tRNA. PLoS ONE 4 (2009) e5908
19. Valencia-Sanchez M.A., Liu J., Hannon G.J., and Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20 (2006) 515-524
20. Pillai R. MicroRNA function: multiple mechanisms for a tiny RNA?. RNA 11 (2005) 1753-1761
21. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., and Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15 (2004) 185-197
22. Doench J.G., and Sharp P.A. Specificity of microRNA target selection in translational repression. Genes Dev. 18 (2004) 504-511
23. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell. Biol. 6 (2005) 376-385
24. Pillai R.S., Bhattacharyya S.N., and Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol. 17 (2007) 118-126
25. Chendrimada T.P., Finn K.J., Ji X., Baillat D., Gregory R.I., Liebhaber S.A., Pasquinelli A.E., and Shiekhattar R. MicroRNA silencing through RISC recruitment of eIF6. Nature 447 (2007) 823-828
26. Kiriakidou M., Tan G.S., Lamprinaki S., De Planell-Saguer M., Nelson P.T., and Mourelatos Z. An mRNA m(7)G Cap binding-like motif within human Ago2 represses translation. Cell 129 (2007) 1141-1151
27. Mathonnet G., et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317 (2007) 1764-1767
28. Kozak M. Faulty old ideas about translational regulation paved the way for current confusion about how microRNAs function. Gene 423 (2008) 108-115
29. Alemán L.M., Doench J., and Sharp P.A. Comparison of siRNA-induced off-target RNA and protein effects. RNA 13 (2007) 385-395
30. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., and Burge C.B. Prediction of mammalian microRNA targets. Cell 115 (2003) 787-798